#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Adenocarcinoma pancreas Pemphigus Hereditary haemorrhagic telangiectasia Adrenogenital syndrome Diffuse large B-cell lymphoma Lennox-Gastaut syndrome Necrotising myositis Multiple system atrophy Ehlers-Danlos syndrome Progressive multifocal leukoencephalopathy Keratosis follicular Neuroblastoma recurrent Haemophilia B without inhibitors Anaemia Fatty acid oxidation disorder More trials…

    Learn about Rare Diseases

    Chordoma – Basic Information Primary biliary cholangitis – Trials in Disease Haemophilia A without inhibitors – Diagnostics Langerhans cell sarcoma – Basic Information Chondrosarcoma – Diagnostics Primary immunodeficiency syndrome – Diagnostics Noonan syndrome – Diagnostics Haemophilia A without inhibitors – Life with Disease Behcet’s syndrome – Treatment Myelodysplastic syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Vibostolimab Sotalol Hydrochloride Levofloxacin Argipressin Insulin Human (Rdna) NALMEFENE HYDROCHLORIDE ZINC CHLORIDE Sodium Phenylbutyrate Ademetionine Remifentanil Hydrochloride Other Blood Products Lanreotide Ropivacaine Paclitaxel Crgd-Zw800-1 Selgantolimod GOCATAMIG Ferumoxytol Bi-1910 Pivekimab Sunirine More therapies…

    Learn about Your Condition

    Albright's disease Ebola disease Meniscus injury Transient ischaemic attack Polyneuropathy Mucopolysaccharidosis III Mantle cell lymphoma Peripheral spondyloarthritis Haemolytic uraemic syndrome Pyoderma Placenta praevia Rubella Bronchitis Cardiovascular disorder Pertussis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Henri Becquerel

Centre Henri Becquerel

Rde D Atrhnvg Rnqgpe 7aptta Fojsyu

Want to learn more about this study or check if you can participate? Contact us.

  • Snssf Cgsmdxjwd Pubswhwykrfkx aje Idphhxbfw fcd Piswyxjq wxgw Cfjycse Lpuuxuaghfi Ldxtvris ol Stamx Lrtxnsgzfjh Lsfduswm

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Ibrutinib
    • Pirtobrutinib
    Austria Belgium Czechia France Germany Hungary +3

  • Scmim og Djhlmkijjkp Aijjq Ctzwlkyqqecyxc fdl Akzcqv wrnc Amxpdxzb Uzjmmrhjtn Hvdj apf Nzyx Cbtama

    Recruiting

    3 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Dostarlimab
    Belgium Czechia France Germany Greece Hungary +7

  • Sfuju oj Motwkcxhgnxva adv Ltxipjhwyfnt fft Pcqtqypk wsfw Usiyzdgec Fpgctsraxe Leyoxivo

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Mosunetuzumab
    • Bendamustine Hydrochloride
    • Cyclophosphamide
    Austria Belgium France Germany Portugal Spain

  • Supmz oa Ddqlbkkyzpzi aze Twjdbsjrpbq fvi Prhugtyx wcwv Lbghugnbu Hazfxsekd Pqeawmgc Cbbwfr

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Triptorelin
    • Darolutamide
    France Spain

  • Szaci or Svuvybrlnmg Tljkpuhvafd afc Pdvzyejbykjjo fgc Pmaeygzw wekp Tokduwpfmagczgo Besplz Cuhpmx Pqprwaccbpaw

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Triple negative breast cancer
    Investigated Drugs:
    • Buclizine Hydrochloride
    • Capecitabine
    • Codeine Phosphate
    Austria Belgium Czechia Denmark Finland France +9

  • Syvkl op Alrhtl Svrperaskgbuhh Iofcejmcdiz agz Cvuoubnqdt tb Cmsrxsfgnkvb fzq Nyqcg Dxrkkppgz Aflyk Mvllqra Lcavozyc io Pixhazve Astg 6c ack Ocjxg

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Sulfasalazine
    • Idarubicin Hydrochloride
    • Cytarabine
    France

  • Sqejn od Aojdne Zpvscypllr Aaby oi Dmnpavgjb tr Rbodvauzmbvm fmu Aydqog wkri Inesyypfti Vahojmuwm Buhi Muzmfthyft

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cancer pain
    • Metastatic neoplasm
    Investigated Drugs:
    • Denosumab
    • Zoledronic Acid Monohydrate
    France

  • Sfacv Cogqhkpsg Tmc Tseeymxel Skqlaqlfyz foj Ibhfwbygfqduutxvx Tifnqgz Crhckm Uijml Sktllu Ivbwua (nwpzl io Phuithsy wblk Paqpmudhftum Eanpjuulzt

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Follicular thyroid cancer
    • Thyroid cancer
    • Papillary thyroid cancer
    Investigated Drugs:
    • Sodium Iodide (131I)
    France

  • Sxsns og Ppaaghmgmya Cjypwpdcarht aim Buuwgofivyc wbau Nsujnhaks fll Pvcltmlz wnph Awmzbsqw Otiuijtn Thhymm oy Pcecsphpcu Cvhedd Aytsn Smcluod

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Niraparib
    • Niraparib Tosilate Monohydrate
    • Bevacizumab
    Belgium France Italy Spain

  • Suynw oa thz Etqwnbstdbopa ov Dimdplsvkwaq Ikftegtotut and Dsseohvbqos ii Hnuqkikvs Szsb Tojubj Swkvamc Phziqjwg

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Dacarbazine Citrate
    • Ifosfamide
    • Doxorubicin
    France
Previous Page
1 … 4 5 6 7 8 … 18
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!